Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-12-18 Sale |
2020-12-22 4:38 pm |
Replimune Group Inc. | REPL | Rhodes Jason P Director |
4,319 | $41.95 | $181,182 | 19,285 (Indirect) |
View |
2020-12-15 Sale |
2020-12-17 6:21 pm |
Replimune Group Inc. | REPL | Rhodes Jason P Director |
65,029 | $42.28 | $2,749,721 | 19,550 (Indirect) |
View |
2020-12-14 Sale |
2020-12-16 9:00 pm |
Replimune Group Inc. | REPL | Franchi Jean M. Chief Financial Officer |
25,000 | $43.45 | $1,086,200 | 155,000 (Direct) |
View |
2020-12-10 Sale |
2020-12-14 7:20 pm |
Replimune Group Inc. | REPL | Rhodes Jason P Director |
103,686 | $43.35 | $4,494,442 | 23,481 (Indirect) |
View |
2020-12-09 Sale |
2020-12-11 9:00 pm |
Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer |
50,000 | $43.4 | $2,169,874 | 1,305,297 (Direct) |
View |
2020-12-09 Sale |
2020-12-11 9:00 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
30,000 | $43.75 | $1,312,382 | 976,524 (Direct) |
View |
2020-12-07 Sale |
2020-12-09 7:54 pm |
Replimune Group Inc. | REPL | Rhodes Jason P Director |
217,362 | $45.92 | $9,981,231 | 29,748 (Indirect) |
View |
2020-12-08 Sale |
2020-12-09 7:50 pm |
Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director |
5,200 | $46 | $239,200 | 31,307 (Direct) |
View |
2020-12-07 Sale |
2020-12-09 7:48 pm |
Replimune Group Inc. | REPL | Dhingra Kapil Director |
40,000 | $45.56 | $1,822,395 | 3,169 (Direct) |
View |
2020-11-16 Sale |
2020-11-18 8:00 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
15,000 | $44.91 | $673,649 | 1,006,524 (Direct) |
View |
2020-10-14 Sale |
2020-10-16 6:05 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
16,000 | $32.9 | $526,410 | 240,903 (Direct) |
View |
2020-09-15 Sale |
2020-09-17 4:25 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
15,000 | $23.97 | $359,487 | 1,021,524 (Direct) |
View |
2020-08-31 Sale |
2020-09-01 5:13 pm |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $27.05 | $135,250 | 256,903 (Direct) |
View |
2020-08-17 Sale |
2020-08-18 5:15 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
15,000 | $23.44 | $351,555 | 1,036,524 (Direct) |
View |
2020-07-09 Sale |
2020-07-10 9:00 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
169,750 | $22.13 | $3,757,295 | 2,024,118 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-12-14 Exercise |
2020-12-16 9:00 pm |
N/A 2029-12-09 |
Replimune Group Inc. | REPL | Franchi Jean M. Chief Financial Officer |
25,000 | $0 | 155,000 (Direct) |
View |
2020-12-14 Exercise |
2020-12-16 9:00 pm |
N/A N/A |
Replimune Group Inc. | REPL | Franchi Jean M. Chief Financial Officer |
25,000 | $14.08 | 155,000 (Direct) |
View |
2020-12-11 Exercise |
2020-12-15 9:35 pm |
N/A 2027-07-26 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
12,590 | $0 | 246,981 (Direct) |
View |
2020-12-11 Exercise |
2020-12-15 9:35 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
12,590 | $3.3 | 246,981 (Direct) |
View |
2020-12-08 Exercise |
2020-12-09 7:50 pm |
N/A 2027-10-01 |
Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director |
5,200 | $0 | 31,307 (Direct) |
View |
2020-12-08 Exercise |
2020-12-09 7:50 pm |
N/A N/A |
Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director |
5,200 | $3.3 | 31,307 (Direct) |
View |
2020-12-07 Exercise |
2020-12-09 7:48 pm |
N/A 2026-01-21 |
Replimune Group Inc. | REPL | Dhingra Kapil Director |
40,000 | $0 | 3,169 (Direct) |
View |
2020-12-07 Exercise |
2020-12-09 7:48 pm |
N/A N/A |
Replimune Group Inc. | REPL | Dhingra Kapil Director |
40,000 | $1.75 | 3,169 (Direct) |
View |
2020-11-02 Option Award |
2020-11-03 4:07 pm |
N/A 2030-11-02 |
Replimune Group Inc. | REPL | Lewis Tanya Director |
33,000 | $0 | 33,000 (Direct) |
View |
2020-10-14 Exercise |
2020-10-16 6:05 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
16,000 | $0 | 240,903 (Direct) |
View |
2020-10-14 Exercise |
2020-10-16 6:05 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
16,000 | $1.01 | 240,903 (Direct) |
View |
2020-09-15 Other |
2020-09-17 4:48 pm |
N/A N/A |
Replimune Group Inc. | REPL | Atlas Venture Fund X L.P. 10% Owner |
445,339 | $0 | 2,931,635 (Direct) |
View |
2020-08-31 Exercise |
2020-09-01 5:13 pm |
N/A 2025-11-01 |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $0 | 256,903 (Direct) |
View |
2020-08-31 Exercise |
2020-09-01 5:13 pm |
N/A N/A |
Replimune Group Inc. | REPL | Esposito Pamela Chief Business Officer |
5,000 | $1.01 | 256,903 (Direct) |
View |
2020-07-20 Option Award |
2020-07-22 08:14 am |
N/A 2030-07-20 |
Replimune Group Inc. | REPL | Pirzkall Andrea Chief Medical Officer |
300,000 | $0 | 300,000 (Direct) |
View |
Ownership |
2020-07-22 08:13 am |
N/A N/A |
Replimune Group Inc. | REPL | Pirzkall Andrea Chief Medical Officer |
0 | $0 | 1,000 (Indirect) |
View |
2020-07-02 Other |
2020-07-07 6:54 pm |
N/A N/A |
Replimune Group Inc. | REPL | Atlas Venture Fund X L.P. 10% Owner |
445,339 | $0 | 3,376,974 (Direct) |
View |
2020-06-16 Other |
2020-06-18 4:37 pm |
N/A N/A |
Replimune Group Inc. | REPL | Atlas Venture Fund X L.P. 10% Owner |
445,339 | $0 | 3,822,313 (Direct) |
View |